Market Research

Oligonucleotides Market (Type: Antisense Oligonucleotides, DNA Oligos, siRNA and Others; Application: Molecular Biology, Gene Therapy, Drug Development, Diagnostics and Others; End-user Hospitals, Pharma & Biopharma Companies, Diagnostic Laboratories, Bio

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 172 Pages Transparency Market Research Pvt. Ltd. November, 2024 TNPR19468671
Best Price Guarantee
Price from $5,795
Length 172 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date November, 2024
SKU TNPR19468671

Oligonucleotides Market (Type: Antisense Oligonucleotides, DNA Oligos, siRNA and Others; Application: Molecular Biology, Gene Therapy, Drug Development, Diagnostics and Others; End-user Hospitals, Pharma & Biopharma Companies, Diagnostic Laboratories, Biotechnology Companies, CROs and CMOs, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Oligonucleotides Market - Scope of Report

TMR's report on the global oligonucleotides market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oligonucleotides market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oligonucleotides market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oligonucleotides market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oligonucleotides market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oligonucleotides market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oligonucleotides market.

The report delves into the competitive landscape of the global oligonucleotides market. Key players operating in the global oligonucleotides market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oligonucleotides market profiled in this report.

Key Questions Answered in Global oligonucleotides Market Report
  • What is the sales/revenue generated by oligonucleotides across all regions during the forecast period?
  • What are the opportunities in the global oligonucleotides market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Oligonucleotides Market - Research Objectives and Research Approach

The comprehensive report on the global oligonucleotides market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global oligonucleotides market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oligonucleotides market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Oligonucleotides Market
4. Market Overview
  4.1. Introduction
4.1.1. Segmentation Definition
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Oligonucleotides Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
  5.1. No. of Oligonucleotides being developed in world by Key Regions
  5.2. List of top Oligonucleotides products
  5.3. Pricing Analysis
  5.4. Go-to-Market Strategy
  5.5. Key Purchase Metrics for End-users
  5.6. PESTEL Analysis
  5.7. Key Industry Events
  5.8. Porter's Five Forces Analysis
  5.9. Regulatory Scenario by Key Countries/Regions
  5.10. Product/Brand Analysis
  5.11. Distributors Landscape
  5.12. Technological Advancements
  5.13. Fund Raise/Investment Scenario
  5.14. Recommendations and Analyst View for the Market
6. Global Oligonucleotides Market Analysis and Forecasts, By Type
  6.1. Introduction & Definition
  6.2. Key Findings / Developments
  6.3. Market Value Forecast By Type, 2020-2034
6.3.1. Antisense Oligonucleotides
6.3.2. DNA
6.3.3. siRNA
6.3.4. Others (CpG Oligonucleotides)
  6.4. Market Attractiveness By Type
7. Global Oligonucleotides Market Analysis and Forecasts, By Application
  7.1. Introduction & Definition
  7.2. Key Findings / Developments
  7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Molecular Biology
7.3.2. Gene Therapy
7.3.3. Drug Development
7.3.4. Diagnostics
7.3.5. Others (Nanotechnology, Research studies etc.)
  7.4. Market Attractiveness By Application
8. Global Oligonucleotides Market Analysis and Forecasts, By End-user
  8.1. Introduction & Definition
  8.2. Key Findings / Developments
  8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Pharma & Biopharma Companies
8.3.3. Diagnostic Laboratories
8.3.4. Biotechnology Companies
8.3.5. CROs and CMOs
8.3.6. Others (Academic Research Institutes, etc.)
  8.4. Market Attractiveness By End-user
9. Global Oligonucleotides Market Analysis and Forecasts, By Region
  9.1. Key Findings
  9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
  9.3. Market Attractiveness By Country/Region
10. North America Oligonucleotides Market Analysis and Forecast
  10.1. Introduction
10.1.1. Key Findings
  10.2. Market Value Forecast By Type, 2020-2034
10.2.1. Antisense Oligonucleotides
10.2.2. DNA
10.2.3. siRNA
10.2.4. Others (CpG Oligonucleotides)
  10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Molecular Biology
10.3.2. Gene Therapy
10.3.3. Drug Development
10.3.4. Diagnostics
10.3.5. Others (Nanotechnology, Research studies etc.)
  10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Pharma & Biopharma Companies
10.4.3. Diagnostic Laboratories
10.4.4. Biotechnology Companies
10.4.5. CROs and CMOs
10.4.6. Others (Academic Research Institutes, etc.)
  10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
  10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Oligonucleotides Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast By Type, 2020-2034
11.2.1. Antisense Oligonucleotides
11.2.2. DNA
11.2.3. siRNA
11.2.4. Others (CpG Oligonucleotides)
  11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Molecular Biology
11.3.2. Gene Therapy
11.3.3. Drug Development
11.3.4. Diagnostics
11.3.5. Others (Nanotechnology, Research studies etc.)
  11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Pharma & Biopharma Companies
11.4.3. Diagnostic Laboratories
11.4.4. Biotechnology Companies
11.4.5. CROs and CMOs
11.4.6. Others (Academic Research Institutes, etc.)
  11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
  11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Oligonucleotides Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast By Type, 2020-2034
12.2.1. Antisense Oligonucleotides
12.2.2. DNA
12.2.3. siRNA
12.2.4. Others (CpG Oligonucleotides)
  12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Molecular Biology
12.3.2. Gene Therapy
12.3.3. Drug Development
12.3.4. Diagnostics
12.3.5. Others (Nanotechnology, Research studies etc.)
  12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Pharma & Biopharma Companies
12.4.3. Diagnostic Laboratories
12.4.4. Biotechnology Companies
12.4.5. CROs and CMOs
12.4.6. Others (Academic Research Institutes, etc.)
  12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
  12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Oligonucleotides Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast By Type, 2020-2034
13.2.1. Antisense Oligonucleotides
13.2.2. DNA
13.2.3. siRNA
13.2.4. Others (CpG Oligonucleotides)
  13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Molecular Biology
13.3.2. Gene Therapy
13.3.3. Drug Development
13.3.4. Diagnostics
13.3.5. Others (Nanotechnology, Research studies etc.)
  13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Pharma & Biopharma Companies
13.4.3. Diagnostic Laboratories
13.4.4. Biotechnology Companies
13.4.5. CROs and CMOs
13.4.6. Others (Academic Research Institutes, etc.)
  13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of LATAM
  13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Oligonucleotides Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast By Type, 2020-2034
14.2.1. Antisense Oligonucleotides
14.2.2. DNA
14.2.3. siRNA
14.2.4. Others (CpG Oligonucleotides)
  14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Molecular Biology
14.3.2. Gene Therapy
14.3.3. Drug Development
14.3.4. Diagnostics
14.3.5. Others (Nanotechnology, Research studies etc.)
  14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Pharma & Biopharma Companies
14.4.3. Diagnostic Laboratories
14.4.4. Biotechnology Companies
14.4.5. CROs and CMOs
14.4.6. Others (Academic Research Institutes, etc.)
  14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. South Africa
14.5.2. GCC Countries
14.5.3. Rest of MEA
  14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  15.2. Market Share Analysis By Company (2023)
  15.3. Company Profiles
15.3.1. Agilent Technologies
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Ajinomoto Bio-Pharma Services
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CordenPharma
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Creative Biolabs
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Ella Biotech
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Eurofins Genomics
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Future synthesis
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Integrated DNA Technologies
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Kaneka Eurogentec
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Thermo Fisher Scientific Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Merck
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Microsynth
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. Nitto Avecia
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings